Skip to main content

Find Clinical Trials

Home
Conditions
Neurotoxicity Syndromes

Clinical trial condition

Neurotoxicity Syndromes

Explore clinical trials studying Neurotoxicity Syndromes. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Neurotoxicity Syndromes trial results

Recruiting

Nerve Excitability in Cisplatin-Induced Peripheral Neuropathy

NCT07095998

Conditions: Chemically-Induced Disorders, Nervous System Diseases, Neuromuscular Diseases, +6 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Assessing DCog Short for Neurotoxicity in CAR-T

NCT07403812

Conditions: Chemically-Induced Disorders, Hematologic Diseases, Hematologic Malignancy, +9 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

NCT04150913

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

To Study the Individual Variants of Chemotherapy-Induced Neurotoxicity

NCT02481336

Conditions: Chemically-Induced Disorders, Nervous System Diseases, Neuromuscular Diseases, +3 more
Locations: National Cheng Kung University Hospital Tainan, Taiwan

View Trial Details